Literature DB >> 7578855

Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata's disease).

Y Eguchi1, Y Uchigata, K Yao, H Yokoyama, Y Hirata, Y Omori.   

Abstract

In a 56-year-old woman with granulomas of gold thioglucose in her hips, who developed insulin autoimmune syndrome, the relationships among the frequency or severity of hypoglycemic attacks, serum insulin (IRI) concentration, and characteristics of insulin antibodies were investigated during the clinical course with steroid treatment and two resection operations for the gold-thioglucose granulomas. When hypoglycemia was severe, the total IRI level was elevated, and Scatchard analysis showed that a high-affinity (k1), low-capacity (b1) population of antibodies had a relatively low affinity constant and very high binding capacity compared with the same population of antibodies in insulin-treated diabetic patients. When the attacks were relieved by steroid treatment and/or granuloma resection operation, the total IRI level was decreased and the high-affinity (k1), low-capacity (b1) population of antibodies showed a higher affinity constant and a lower binding capacity than those during the attacks. This indicated that the antibodies changed their characteristics to release insulin into the serum. The k1/b1 population of insulin antibodies with the lower affinity constant and higher binding capacity may easily release human insulin into the serum, leading to hypoglycemia. The longitudinal change of the k1/b1 population suggests a clonal change of the B cells producing the insulin antibody in insulin autoimmune syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7578855     DOI: 10.3109/08916939409071354

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

1.  Production of insulin antibody associated with relapsed hodgkin's lymphoma.

Authors:  Masatoshi Ikeda; Masaki Fujimura; Kentaro Kurosawa; Shunsuke Tsugawa; Yui Sakuramachi; Kiyoko Takano; Shintaro Okamura; Masako Kitatani; Futoshi Iioka; Satoru Tsujii; Yasuaki Hayashino
Journal:  Diabetol Int       Date:  2021-10-16

2.  The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes.

Authors:  D Devendra; T S Galloway; S J Horton; A Evenden; U Keller; T J Wilkin
Journal:  Diabetologia       Date:  2003-06-03       Impact factor: 10.122

3.  Insulin autoimmune syndrome in a patient with ANCA-associated glomerulonephritis.

Authors:  Tsuneyoshi Ka; Yuji Moriwaki; Takeshi Nakanishi; Tetsuya Yamamoto
Journal:  Diabetes Metab Syndr Obes       Date:  2008-06-19       Impact factor: 3.168

4.  Two cases of methimazole-induced insulin autoimmune syndrome in graves' disease.

Authors:  Eun Roh; Ye An Kim; Eu Jeong Ku; Jae Hyun Bae; Hye Mi Kim; Young Min Cho; Young Joo Park; Kyong Soo Park; Seong Yeon Kim; Soo Heon Kwak
Journal:  Endocrinol Metab (Seoul)       Date:  2013-03-25

5.  Rare association of insulin autoimmune syndrome with ankylosing spondylitis.

Authors:  Nishant Raizada; S H Rahaman; D Kandasamy; V P Jyotsna
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-09-24

6.  Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: A rare case report.

Authors:  Yiyi Zhang; Tieyun Zhao
Journal:  Exp Ther Med       Date:  2014-09-15       Impact factor: 2.447

7.  Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018): Congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata's disease).

Authors:  Yuki Yamada; Kana Kitayama; Maki Oyachi; Shinji Higuchi; Rie Kawakita; Yutaka Kanamori; Tohru Yorifuji
Journal:  J Diabetes Investig       Date:  2019-12-24       Impact factor: 4.232

8.  Recurrent Hypoglycemia Due to a High Titer of Insulin Antibody in Response to Exogenous Insulin Administration in Two Cases of Type 1 Diabetes.

Authors:  Ryoichi Kawamura; Satoshi Miyao; Hiroshi Onuma; Yasuko Uchigata; Eiji Kawasaki; Jun Ohashi; Sanshiro Shiraishi; Wataru Nishida; Maki Yokomoto-Umakoshi; Yasunori Takata; Haruhiko Osawa; Hideichi Makino
Journal:  Intern Med       Date:  2021-08-31       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.